860 related articles for article (PubMed ID: 9162739)
1. Ca(2+)-binding proteins S100A6 and S100B in primary cutaneous melanoma.
Böni R; Heizmann CW; Doguoglu A; Ilg EC; Schäfer BW; Dummer R; Burg G
J Cutan Pathol; 1997 Feb; 24(2):76-80. PubMed ID: 9162739
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
[TBL] [Abstract][Full Text] [Related]
3. Expression pattern of S100 calcium-binding proteins in human tumors.
Ilg EC; Schäfer BW; Heizmann CW
Int J Cancer; 1996 Nov; 68(3):325-32. PubMed ID: 8903474
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotypic markers to differentiate between benign and malignant melanocytic lesions.
Keijser S; Missotten GS; Bonfrer JM; de Wolff-Rouendaal D; Jager MJ; de Keizer RJ
Br J Ophthalmol; 2006 Feb; 90(2):213-7. PubMed ID: 16424536
[TBL] [Abstract][Full Text] [Related]
5. Primary mucosal malignant melanoma: an immunohistochemical study of 12 cases with comparison to cutaneous and metastatic melanomas.
Fitzgibbons PL; Chaurushiya PS; Nichols PW; Chandrasoma PT; Martin SE
Hum Pathol; 1989 Mar; 20(3):269-72. PubMed ID: 2722176
[TBL] [Abstract][Full Text] [Related]
6. Development and progression of malignancy in human colon tissues are correlated with expression of specific Ca(2+)-binding S100 proteins.
Bronckart Y; Decaestecker C; Nagy N; Harper L; Schäfer BW; Salmon I; Pochet R; Kiss R; Heizman CW
Histol Histopathol; 2001 Jul; 16(3):707-12. PubMed ID: 11510959
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of S100B and S100A6(1) in the human fetal and aged cerebral cortex.
Tiu SC; Chan WY; Heizmann CW; Schäfer BW; Shu SY; Yew DT
Brain Res Dev Brain Res; 2000 Feb; 119(2):159-68. PubMed ID: 10675765
[TBL] [Abstract][Full Text] [Related]
8. The identification and differential expression of calcium-binding proteins associated with ocular melanoma.
Van Ginkel PR; Gee RL; Walker TM; Hu DN; Heizmann CW; Polans AS
Biochim Biophys Acta; 1998 Dec; 1448(2):290-7. PubMed ID: 9920419
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of S100A6 and matrix metalloproteinase 9, but not S100A2, S100A4, and S100A7, is associated with epidermal carcinogenesis.
Zhu L; Kohda F; Nakahara T; Chiba T; Tsuji G; Hachisuka J; Ito T; Tu Y; Moroi Y; Uchi H; Furue M
J Dermatol Sci; 2013 Dec; 72(3):311-9. PubMed ID: 23993025
[TBL] [Abstract][Full Text] [Related]
10. S100A6 and S100A11 are specific targets of the calcium- and zinc-binding S100B protein in vivo.
Deloulme JC; Assard N; Mbele GO; Mangin C; Kuwano R; Baudier J
J Biol Chem; 2000 Nov; 275(45):35302-10. PubMed ID: 10913138
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of S-100 beta in choroidal melanomas.
Martins MC; Scull JJ; Alcocer CE; Deschênes J; Antecka E; Burnier MN
Can J Ophthalmol; 1997 Oct; 32(6):378-81. PubMed ID: 9363341
[TBL] [Abstract][Full Text] [Related]
12. Localization of Ca(2+)-binding S100 proteins in epithelial tumours of the skin.
Shrestha P; Muramatsu Y; Kudeken W; Mori M; Takai Y; Ilg EC; Schafer BW; Heizmann CW
Virchows Arch; 1998 Jan; 432(1):53-9. PubMed ID: 9463588
[TBL] [Abstract][Full Text] [Related]
13. Melan A and S100 protein immunohistochemistry in feline melanomas: 48 cases.
Ramos-Vara JA; Miller MA; Johnson GC; Turnquist SE; Kreeger JM; Watson GL
Vet Pathol; 2002 Jan; 39(1):127-32. PubMed ID: 12102204
[TBL] [Abstract][Full Text] [Related]
14. Expression of members of the S100 Ca2+-binding protein family in guinea-pig smooth muscle.
Daub B; Schroeter M; Pfitzer G; Ganitkevich V
Cell Calcium; 2003 Jan; 33(1):1-10. PubMed ID: 12526882
[TBL] [Abstract][Full Text] [Related]
15. Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma.
Maelandsmo GM; Flørenes VA; Mellingsaeter T; Hovig E; Kerbel RS; Fodstad O
Int J Cancer; 1997 Aug; 74(4):464-9. PubMed ID: 9291441
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors.
Nonaka D; Chiriboga L; Rubin BP
J Cutan Pathol; 2008 Nov; 35(11):1014-9. PubMed ID: 18547346
[TBL] [Abstract][Full Text] [Related]
17. Expression of S100 protein family members in normal skin and sweat gland tumors.
Zhu L; Okano S; Takahara M; Chiba T; Tu Y; Oda Y; Furue M
J Dermatol Sci; 2013 Jun; 70(3):211-9. PubMed ID: 23623205
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of heterodimer formation between S100B and S100A6 in the yeast two-hybrid system and human melanoma.
Yang Q; O'Hanlon D; Heizmann CW; Marks A
Exp Cell Res; 1999 Feb; 246(2):501-9. PubMed ID: 9925766
[TBL] [Abstract][Full Text] [Related]
19. S100A6 expression in fibrohistiocytic lesions.
Fullen DR; Reed JA; Finnerty B; McNutt NS
J Cutan Pathol; 2001 May; 28(5):229-34. PubMed ID: 11401666
[TBL] [Abstract][Full Text] [Related]
20. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases.
Ben-Izhak O; Stark P; Levy R; Bergman R; Lichtig C
Am J Dermatopathol; 1994 Jun; 16(3):241-6. PubMed ID: 7524376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
